Suppr超能文献

阿霉素、DNA扭转与染色质动力学

Doxorubicin, DNA torsion, and chromatin dynamics.

作者信息

Yang Fan, Teves Sheila S, Kemp Christopher J, Henikoff Steven

机构信息

Basic Science Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

出版信息

Biochim Biophys Acta. 2014 Jan;1845(1):84-9. doi: 10.1016/j.bbcan.2013.12.002. Epub 2013 Dec 19.

Abstract

Doxorubicin is one of the most important anti-cancer chemotherapeutic drugs, being widely used for the treatment of solid tumors and acute leukemias. The action of doxorubicin and other anthracycline drugs has been intensively investigated during the last several decades, but the mechanisms that have been proposed for cell killing remain disparate and controversial. In this review, we examine the proposed models for doxorubicin action from the perspective of the chromatin landscape, which is altered in many types of cancer due to recurrent mutations in chromatin modifiers. We highlight recent evidence for effects of anthracyclines on DNA torsion and chromatin dynamics that may underlie basic mechanisms of doxorubicin-mediated cell death and suggest new therapeutic strategies for cancer treatment.

摘要

阿霉素是最重要的抗癌化疗药物之一,广泛用于实体瘤和急性白血病的治疗。在过去几十年中,人们对阿霉素和其他蒽环类药物的作用进行了深入研究,但提出的细胞杀伤机制仍然各不相同且存在争议。在本综述中,我们从染色质景观的角度审视了阿霉素作用的提出模型,由于染色质修饰剂的反复突变,在许多类型的癌症中染色质景观都发生了改变。我们强调了蒽环类药物对DNA扭转和染色质动力学影响的最新证据,这些可能是阿霉素介导的细胞死亡基本机制的基础,并提出了癌症治疗的新策略。

相似文献

1
Doxorubicin, DNA torsion, and chromatin dynamics.
Biochim Biophys Acta. 2014 Jan;1845(1):84-9. doi: 10.1016/j.bbcan.2013.12.002. Epub 2013 Dec 19.
2
Doxorubicin enhances nucleosome turnover around promoters.
Curr Biol. 2013 May 6;23(9):782-7. doi: 10.1016/j.cub.2013.03.043. Epub 2013 Apr 18.
4
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity.
Oxid Med Cell Longev. 2017;2017:1521020. doi: 10.1155/2017/1521020. Epub 2017 Oct 18.
6
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin.
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15182-15192. doi: 10.1073/pnas.1922072117. Epub 2020 Jun 17.
7
Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs.
Cancer Res. 2018 Mar 15;78(6):1431-1443. doi: 10.1158/0008-5472.CAN-17-2690. Epub 2018 Jan 16.
8
Interaction between second generation anthracyclines and DNA in the nucleosomal structure.
Nucleic Acids Res. 1991 May 11;19(9):2309-14. doi: 10.1093/nar/19.9.2309.
9
New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals.
Anticancer Drugs. 2011 Feb;22(2):176-84. doi: 10.1097/cad.0b013e328341a17b.
10
Re-Exploring the Anthracycline Chemical Space for Better Anti-Cancer Compounds.
J Med Chem. 2023 Aug 24;66(16):11390-11398. doi: 10.1021/acs.jmedchem.3c00853. Epub 2023 Aug 10.

引用本文的文献

1
PI3K/Akt1 Pathway Suppression by Quercetin-Doxorubicin Combination in Osteosarcoma Cell Line (MG-63 Cells).
Medicina (Kaunas). 2025 Jul 25;61(8):1347. doi: 10.3390/medicina61081347.
2
Isolation, Characterization, and Anticancer Evaluation of Alkaloids from (Rubiaceae).
ACS Omega. 2025 Aug 4;10(32):35719-35737. doi: 10.1021/acsomega.5c02401. eCollection 2025 Aug 19.
5
A promising platform of hypoxia sensitive magnetosomes in hepatocellular carcinoma therapy.
Sci Rep. 2025 Jul 11;15(1):25031. doi: 10.1038/s41598-025-10353-y.
6
DNA-damage-associated protein co-expression network in cardiomyocytes informs on tolerance to genetic variation and disease.
iScience. 2025 Apr 18;28(5):112474. doi: 10.1016/j.isci.2025.112474. eCollection 2025 May 16.
7
Different Mechanisms in Doxorubicin-Induced Neurotoxicity: Impact of BRCA Mutations.
Int J Mol Sci. 2025 May 15;26(10):4736. doi: 10.3390/ijms26104736.
9
10
Pathophysiology of Doxorubicin-Mediated Cardiotoxicity.
Toxics. 2025 Apr 5;13(4):277. doi: 10.3390/toxics13040277.

本文引用的文献

1
Transcription-generated torsional stress destabilizes nucleosomes.
Nat Struct Mol Biol. 2014 Jan;21(1):88-94. doi: 10.1038/nsmb.2723. Epub 2013 Dec 8.
2
Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells.
PLoS One. 2013 Oct 7;8(10):e76676. doi: 10.1371/journal.pone.0076676. eCollection 2013.
4
Doxorubicin enhances nucleosome turnover around promoters.
Curr Biol. 2013 May 6;23(9):782-7. doi: 10.1016/j.cub.2013.03.043. Epub 2013 Apr 18.
6
Histone acetylation regulates intracellular pH.
Mol Cell. 2013 Jan 24;49(2):310-21. doi: 10.1016/j.molcel.2012.10.025. Epub 2012 Nov 29.
7
8
Identification of the molecular basis of doxorubicin-induced cardiotoxicity.
Nat Med. 2012 Nov;18(11):1639-42. doi: 10.1038/nm.2919. Epub 2012 Oct 28.
9
Measuring genome-wide nucleosome turnover using CATCH-IT.
Methods Enzymol. 2012;513:169-84. doi: 10.1016/B978-0-12-391938-0.00007-0.
10
Topoisomerase II is required for the production of long Pol II gene transcripts in yeast.
Nucleic Acids Res. 2012 Sep;40(16):7907-15. doi: 10.1093/nar/gks626. Epub 2012 Jun 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验